当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 资产负债表

东方生物

(688298)

  

流通市值:52.94亿  总市值:52.94亿
流通股本:2.02亿   总股本:2.02亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金2,604,809,193.173,081,496,804.82,862,715,435.643,042,661,596.65
应收票据及应收账款192,372,694.5230,166,750.51272,856,154.48273,098,270.39
其中:应收票据1,276,4552,084,470.321,804,684.991,343,870
应收账款191,096,239.5228,082,280.19271,051,469.49271,754,400.39
预付款项32,136,394.4928,448,863.1137,836,957.1240,893,926.75
其他应收款合计17,010,163.9519,115,158.7320,365,778.3123,551,802.25
存货296,948,644.63308,960,712.66427,260,228.2426,262,260.06
其他流动资产111,736,085.37102,998,159.3995,749,351.2390,573,049.83
流动资产平衡项目0000
流动资产合计3,583,909,471.493,978,764,707.924,560,590,159.964,805,209,149.17
非流动资产:
长期股权投资26,267,094.6620,418,460.7119,552,807.8819,693,600.26
其他非流动金融资产29,700,752.4929,846,844.6630,727,585.0530,869,031.61
投资性房地产--19,725,521.6519,884,514.09
固定资产1,526,229,795.91,541,055,701.041,480,517,831.211,496,124,317.33
在建工程1,228,302,023.421,134,471,278.02964,133,871.35886,471,113.89
使用权资产60,390,877.2765,092,573.5971,998,913.3273,517,267.94
无形资产670,752,732.8690,906,710.19712,952,668.84733,297,562.46
商誉--55,367,499.5755,367,499.57
长期待摊费用54,527,494.1859,710,254.9661,443,673.565,150,659.49
递延所得税资产271,730,195.99268,465,824.07233,749,890.27227,339,767.97
其他非流动资产307,351,513.43305,847,891.3823,643,591.2830,018,347.63
非流动资产平衡项目0000
非流动资产合计4,175,252,480.144,115,815,538.623,673,813,853.923,637,733,682.24
资产平衡项目0000
资产总计7,759,161,951.638,094,580,246.548,234,404,013.888,442,942,831.41
流动负债:
短期借款177,519,344.8116,779,303.25186,735,657.38186,711,935.39
应付票据及应付账款480,754,141.22515,489,098.34380,038,865.78392,870,582.65
其中:应付票据--3,000,0004,200,000
应付账款480,754,141.22515,489,098.34377,038,865.78388,670,582.65
预收款项00--
合同负债35,768,144.3530,987,531.7633,556,760.7834,702,545.15
应付职工薪酬35,660,662.8161,148,228.7640,731,287.0137,230,341.78
应交税费9,701,395.0414,895,003.733,696,722.742,558,758.31
其他应付款合计115,334,047.58138,393,080.87143,521,360.39157,700,097.9
一年内到期的非流动负债30,788,482.47324,816,838.85324,199,973.87373,126,703.15
其他流动负债1,199,274.341,292,487.981,488,852.841,681,242.23
流动负债平衡项目0000
流动负债合计886,725,492.611,203,801,573.541,113,969,480.791,186,582,206.56
非流动负债:
长期借款115,133,9500--
租赁负债40,498,031.7347,166,578.6953,160,520.6653,502,584.67
长期应付款7,678,821.737,492,019.94--
预计负债17,622,00017,469,6665,906,9435,697,090
递延收益26,771,826.3626,984,585.0410,110,237.5410,322,996.22
递延所得税负债0232,666.6929,510.2966,060.68
非流动负债平衡项目0000
非流动负债合计207,704,629.8299,345,516.3669,207,211.4969,588,731.57
负债平衡项目0000
负债合计1,094,430,122.431,303,147,089.91,183,176,692.281,256,170,938.13
所有者权益(或股东权益):
实收资本(或股本)201,600,000201,600,000201,600,000201,600,000
资本公积397,885,635.81397,885,635.81396,393,270.49395,773,417.88
减:库存股276,947,754.62276,947,754.62276,947,754.62275,000,000
其他综合收益47,081,400.154,902,604.624,820,019.444,943,151.68
盈余公积84,000,00084,000,00084,000,00084,000,000
未分配利润6,068,198,335.366,183,650,819.316,450,517,323.766,561,066,091.63
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计6,521,817,616.656,645,091,305.16,880,382,859.037,012,382,661.19
少数股东权益142,914,212.55146,341,851.54170,844,462.57174,389,232.09
股东权益平衡项目0000
股东权益合计6,664,731,829.26,791,433,156.647,051,227,321.67,186,771,893.28
负债和股东权益合计7,759,161,951.638,094,580,246.548,234,404,013.888,442,942,831.41
公告日期2025-04-302025-04-302024-10-312024-08-30
审计意见(境内)标准无保留意见
TOP↑